Abstract
Background
RPE cells are a major player in various diseases of the retina and choroid. Proliferating RPE cells are thought to be an initiating factor in proliferative vitreoretinopathy (PVR); the aging RPE cells are important in age-related macular degeneration (AMD). Early passages of cultured human retinal pigment epithelial cells were used as a model system to identify differentially expressed genes in proliferating retinal pigment epithelial (RPE) cells.
Methods
A differential expression analysis (DEmRNA-PCR) was used to find differentially expressed mRNA in early passages of cultured human RPE cells. The detected mRNAs were identified by sequencing. Their differential expression was verified by semi-quantitative RT-PCR. The expression of the identified protein in vitro and its presence in surgically removed epiretinal membranes was demonstrated by western blotting and immunocytochemical analysis.
Results
DEmRNA-PCR detected a decreased expression of a band at approximately 530 bp in human RPE cells of passage 3 (P3) compared to P0. This band was identified as part of the human complement regulatory factor H, a cofactor to complement factor I. The mRNA expression of both regulatory proteins of the complement system was confirmed in freshly prepared human RPE cells and in cultured cells from P0 to P8. The protein expression was verified in cultured RPE cells. The expression of both proteins in surgically removed epiretinal membranes was demonstrated by immunohistochemistry.
Conclusion
The identification of the differential expression of the regulatory factors H and I of the complement system in cultured RPE cells by a technique without any prerequisites demonstrates and confirms the importance of these factors in RPE cells. In addition to its known role in age-related macular degeneration, the presence of these complement factors in epiretinal membranes may also indicate a role of the complement system in proliferative retinopathy.
Similar content being viewed by others
References
Abe T, Durlu YK, Tamai M (1996) The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells. Exp Eye Res 63:201–210
Bardenstein DS, Sauer S, Szczotka L, Medof ME (1997) Detection of complement regulatory proteins on soft contact lenses. Curr Eye Res 16:1270–1273
Baudouin C, Fredj-Reygrobellet D, Gordon WC, Baudouin F, Peyman G, Lapalus P, Gastaud P, Bazan NG (1990) Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol 110:593–598
Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34:3579–3584
Campochiaro PA (1997) Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 115:237–241
Chen M, Forrester JV, Xu H (2007) Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res 84:635–645
DiScipio RG (1992) Ultrastructures and interactions of complement factors H and I. J Immunol 149:2592–2599
Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424
Esser P, Grisanti S, Kociok N, Abts H, Hueber A, Unfried K, Heimann K, Weller M (1997) Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 38:2852–2856
Gao BB, Chen X, Timothy N, Aiello LP, Feener EP (2008) Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 7:2516–2525
Gerritsma JS, Gerritsen AF, De LM, Van EL, Daha MR (1997) Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 9:276–283
Grisanti S, Weller WP, Heimann K, Zilles K (1991) The significance of complement in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 32:2711–2717
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227–7232
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419–421
Kim YH, He S, Kase S, Kitamura M, Ryan SJ, Hinton DR (2009) Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes Arch Clin Exp Ophthalmol 247:651–659
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389
Kociok N, Esser P, Unfried K, Parker F, Schraermeyer U, Grisanti S, Toque B, Heimann K (1999) Upregulation of the RAS-GTPase activating protein (GAP)-binding protein (G3BP) in proliferating RPE cells. J Cell Biochem 74:194–201
Kociok N, Unfried K, Esser P, Krott R, Schraermeyer U, Heimann K (1998) The nonradioisotopic representation of differentially expressed mRNA by a combination of RNA fingerprinting and differential display. Mol Biotechnol 9:25–33
Lappin DF, Guc D, Hill A, McShane T, Whaley K (1992) Effect of interferon-gamma on complement gene expression in different cell types. Biochem J 281:437–442
Lass JH, Walter EI, Burris TE, Grossniklaus HE, Roat MI, Skelnik DL, Needham L, Singer M, Medof ME (1990) Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 31:1136–1148
Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 61:201–283
Liversidge J, Dawson R, Hoey S, McKay D, Grabowski P, Forrester JV (1996) CD59 and CD48 expressed by rat retinal pigment epithelial cells are major ligands for the CD2-mediated alternative pathway of T cell activation. J Immunol 156:3696–3703
Luo W, Vik DP (1999) Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand J Immunol 49:487–494
Mandal MN, Ayyagari R (2006) Complement factor H: spatial and temporal expression and localization in the eye. Invest Ophthalmol Vis Sci 47:4091–4097
Meri S, Jarva H (1998) Complement regulation. Vox Sang 74(Suppl 2):291–302
Minta JO, Fung M, Paramaswara B (1998) Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Biochim Biophys Acta 1442:286–295
Morgan BP, Gasque P, Singhrao S, Piddlesden SJ (1997) The role of complement in disorders of the nervous system [In Process Citation]. Immunopharmacology 38:43–50
Pangburn M, Müller-Eberhard H (1984) The alternative pathway of complement. Springer Semin Immunopathol 7:163–192
Reid KB (1986) Activation and control of the complement system. Essays Biochem 22(27–68):27–68
Ripoche J, Mitchell JA, Erdei A, Madin C, Moffatt B, Mokoena T, Gordon S, Sim RB (1988) Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J Exp Med 168:1917–1922
de Rodriguez CS, Esparza-Gordillo J, de Goicoechea JE, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355–367
Soames CJ, Sim RB (1997) Interactions between human complement components factor H, factor I and C3b. Biochem J 326:553–561
Tsiftsoglou SA, Arnold JN, Roversi P, Crispin MD, Radcliffe C, Lea SM, Dwek RA, Rudd PM, Sim RB (2006) Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides. Biochim Biophys Acta 1764:1757–1766
Yang P, Tyrrell J, Han I, Jaffe GJ (2009) Expression and modulation of RPE cell membrane complement regulatory proteins. Invest Ophthalmol Vis Sci 50:3473–3481
Yu J, Liu F, Cui SJ, Liu Y, Song ZY, Cao H, Chen FE, Wang WJ, Sun T, Wang F (2008) Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics 8:3667–3678
Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J, Hoh J, Abecasis GR, Swaroop A (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77:149–153
Acknowledgment
This study was supported by DFG Jo 324/ 6-2 (Emmy Noether Program) and DFG Jo 324 / 7-1.
The authors thank Beatrix Martiny and Claudia Gavranic for expert technical assistance, as well as the surgical staff from the Department of Vitreoretinal Surgery, University of Cologne for providing epiretinal membrane specimens.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary materials
Below is the link to the electronic supplementary material.
ESM 1
(JPEG 1068 kb)
Rights and permissions
About this article
Cite this article
Kociok, N., Joussen, A.M. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells. Graefes Arch Clin Exp Ophthalmol 248, 1145–1153 (2010). https://doi.org/10.1007/s00417-010-1371-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-010-1371-4